Downregulation of osteoblast Phex expression by PTH

Bone

Volumn 37, Issue 4, 2005, Pages 589-598

  Alos, Nathalie ^a,b   Ecarot, Brigitte ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Mineralization; Mouse; Osteoblast; Phex; PTH

Indexed keywords

CALCIUM 45; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; METHIONINE; PARATHYROID HORMONE[1-34]; SULFUR 35;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITOMETRY; BONE DEVELOPMENT; BONE MINERALIZATION; CALVARIA; CARBOXY TERMINAL SEQUENCE; CELL LABELING; CELL LYSATE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; GENE FUNCTION; HORMONAL REGULATION; IMMUNOPRECIPITATION; INCUBATION TIME; MEDICAL ASSESSMENT; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; PARATHYROID HORMONE RELEASE; PHOSPHATE REGULATING GENE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; REGULATOR GENE;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CALCIFICATION, PHYSIOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION; MICE; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; PARATHYROID HORMONE;

EID: 24944550068     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.05.006     Document Type: Article

References (56)

1. H. Rasmussen, and H.S. Tenenhouse Mendelian hypophosphatemias C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The metabolic and molecular basis of inherited diseases 1995 Mc-Graw Hill Book Co. New York, NY, USA 3717 3745
2. F. Albright, A.M. Butler, and E. Bloomberg Rickets resistant to vitamin D therapy Am. J. Dis. Child 54 1937 529
3. K.A. Hruska, L. Rifas, S.L. Cheng, A. Gupta, L. Halstead, and L. Avioli X-linked hypophosphatemic rickets and the murine Hyp homologue Am. J. Physiol. 268 3 Pt 2 1995 F357 F362
4. T. Nesbitt, T.M. Coffman, R. Griffiths, and M.K. Drezner Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect J. Clin. Invest. 89 5 1992 1453 1459
5. B. Ecarot, F.H. Glorieux, M. Desbarats, R. Travers, and L. Labelle Defective bone formation by Hyp mouse bone cells transplanted into normal mice: evidence in favor of an intrinsic osteoblast defect J. Bone Miner. Res. 7 2 1992 215 220
6. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP consortium Nat. Genet. 11 2 1995 130 136
7. P.S. Rowe, C.L. Oudet, F. Francis, C. Sinding, S. Pannetier, and M.J. Econs Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP) Hum. Mol. Genet. 6 4 1997 539 549
8. T.M. Strom, F. Francis, B. Lorenz, A. Boddrich, M.J. Econs, and H. Lehrach Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia Hum. Mol. Genet. 6 2 1997 165 171
9. I.A. Holm, X. Huang, and L.M. Kunkel Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets Am. J. Hum. Genet. 60 4 1997 790 797
10. L. Beck, Y. Soumounou, J. Martel, G. Krishnamurthy, C. Gauthier, and C.G. Goodyer Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice J. Clin. Invest 99 6 1997 (3-15) 1200 1209
11. A.F. Ruchon, M. Marcinkiewicz, G. Siegfried, H.S. Tenenhouse, L. DesGroseillers, and P. Crine Pex MRNA is localized in developing mouse osteoblasts and odontoblasts J. Histochem. Cytochem. 46 4 1998 459 468
12. L. Du, M. Desbarats, J. Viel, F.H. Glorieux, C. Cawthorn, and B. Ecarot CDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone Genomics 36 1 1996 (8-15) 22 28
13. B. Ecarot, and M. Desbarats 1,25-(OH)2D3 down-regulates expression of Phex, a marker of the mature osteoblast Endocrinology 140 3 1999 1192 1199
14. M.J. Econs New insights into the pathogenesis of inherited phosphate wasting disorders Bone 25 1 1999 131 135
15. M.K. Drezner PHEX gene and hypophosphatemia Kidney Int. 57 1 2000 9 18
16. C. Arnaud, F. Glorieux, and C. Scriver Serum parathyroid hormone in X-linked hypophosphatemia Science 173 999 1971 (8-27) 845 847
17. F.H. Glorieux, P.J. Marie, J.M. Pettifor, and E.E. Delvin Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets N. Engl. J. Med. 303 18 1980 (10-30) 1023 1031
18. W.F. Falls Jr., N.W. Carter, F.C. Rector Jr., and D.W. Seldin Familial vitamin D-resistant rickets. Study of six cases with evaluation of the pathogenetic role of secondary hyperparathyroidism Ann. Intern. Med. 68 3 1968 553 560
19. S.A. Rivkees, G. Hajj-Fuleihan, E.M. Brown, and J.D. Crawford Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets J. Clin. Endocrinol. Metab. 75 6 1992 1514 1518
20. T.D. Blydt-Hansen, H.S. Tenenhouse, and P. Goodyer PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia Pediatr. Nephrol. 13 7 1999 607 611
21. M. Mannstadt, H. Juppner, and T.J. Gardella Receptors for PTH and PTHrP: their biological importance and functional properties Am. J. Physiol. 277 5 Pt 2 1999 F665 F675
22. D.W. Dempster, F. Cosman, M. Parisien, V. Shen, and R. Lindsay Anabolic actions of parathyroid hormone on bone Endocr. Rev. 14 6 1993 690 709
23. Y. Isogai, T. Akatsu, T. Ishizuya, A. Yamaguchi, M. Hori, and N. Takahashi Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages J. Bone Miner. Res. 11 10 1996 1384 1393
24. T. Ishizuya, S. Yokose, M. Hori, T. Noda, T. Suda, and S. Yoshiki Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells J. Clin. Invest. 99 12 1997 (6-15) 2961 2970
25. P.C. Schiller, G. D'Ippolito, B.A. Roos, and G.A. Howard Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment J. Bone Miner. Res. 14 9 1999 1504 1512
26. R.A. Meyer Jr., M.H. Meyer, and R.W. Gray Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice J. Bone Miner. Res. 4 4 1989 493 500
27. M.J. Econs, and M.K. Drezner Tumor-induced osteomalacia-Unveiling a new hormone N. Engl. J. Med. 330 23 1994 (6-9) 1679 1681
28. M.L. Lipman, D. Panda, H.P. Bennett, J.E. Henderson, E. Shane, and Y. Shen Cloning of human PEX CDNA. Expression, subcellular localization, and endopeptidase activity J. Biol. Chem. 273 22 1998 (5-29) 13729 13737
29. S.C. Schiavi, and O.W. Moe Phosphatonins: a new class of phosphate-regulating proteins Curr. Opin. Nephrol. Hypertens. 11 4 2002 423 430
30. A. Benet-Pages, B. Lorenz-Depiereux, H. Zischka, K.E. White, M.J. Econs, and T.M. Strom FGF23 is processed by proprotein convertases but not by PHEX Bone 35 2 2004 455 462
31. S. Liu, R. Guo, L.G. Simpson, Z.S. Xiao, C.E. Burnham, and L.D. Quarles Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX J. Biol. Chem. 278 39 2003 (9-26) 37419 37426
32. T.J. Weber, S. Liu, O.S. Indridason, and L.D. Quarles Serum FGF23 levels in normal and disordered phosphorus homeostasis J Bone Miner. Res. 18 7 2003 1227 1234
33. S. Liu, T.A. Brown, J. Zhou, Z.S. Xiao, H. Awad, and F. Guilak Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia J. Am. Soc. Nephrol. 2005 (4-20)
34. B. Ecarot-Charrier, F.H. Glorieux, R. Travers, M. Desbarats, F. Bouchard, and A. Hinek Defective bone formation by transplanted Hyp mouse bone cells into normal mice Endocrinology 123 2 1988 768 773
35. X. Bai, D. Miao, D. Panda, S. Grady, M.D. McKee, and D. Goltzman Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) Expression Mol. Endocrinol. 16 12 2002 2913 2925
36. D. Miao, X. Bai, D. Panda, M. McKee, A. Karaplis, and D. Goltzman Osteomalacia in Hyp mice is associated with abnormal Phex expression and with altered bone matrix protein expression and deposition Endocrinology 142 2 2001 926 939
37. R. Guo, and L.D. Quarles Cloning and sequencing of human PEX from a bone CDNA library: evidence for its developmental stage-specific regulation in osteoblasts J. Bone Miner. Res. 12 7 1997 1009 1017
38. D.L. Thompson, Y. Sabbagh, H.S. Tenenhouse, P.C. Roche, M.K. Drezner, and J.L. Salisbury Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts J. Bone Miner. Res. 17 2 2002 311 320
39. E.R. Hines, J.F. Collins, M.D. Jones, S.H. Serey, and F.K. Ghishan Glucocorticoid regulation of the murine PHEX gene Am. J. Physiol. Renal. Physiol. 283 2 2002 F356 F363
40. E. Zoidis, M. Gosteli-Peter, C. Ghirlanda-Keller, L. Meinel, J. Zapf, and C. Schmid IGF-I and GH stimulate Phex MRNA expression in lungs and bones and 1,25-dihydroxyvitamin D(3) production in hypophysectomized rats Eur. J. Endocrinol. 146 1 2002 97 105
41. M.A. Vargas, M. St Louis, L. DesGroseillers, J.L. Charli, and G. Boileau Parathyroid hormone-related protein (1-34) regulates Phex expression in osteoblasts through the protein kinase A pathway Endocrinology 144 11 2003 4876 4885
42. S.K. Lee, and J.A. Lorenzo Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation Endocrinology 140 8 1999 3552 3561
43. J. Reeve, M. Arlot, M. Bernat, S. Charhon, C. Edouard, and D. Slovik Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (HPTH 1-34) therapy Metab. Bone Dis. Relat. Res. 3 1 1981 23 30
44. A.B. Hodsman, D.A. Hanley, M.P. Ettinger, M.A. Bolognese, J. Fox, and A.J. Metcalfe Efficacy and safety of human parathyroid hormone- (1-84) in increasing bone mineral density in postmenopausal osteoporosis J. Clin. Endocrinol. Metab. 88 11 2003 5212 5220
45. J.M. Hock, and I. Gera Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone J. Bone Miner. Res. 7 1 1992 65 72
46. C.S. Tam, J.N. Heersche, T.M. Murray, and J.A. Parsons Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration Endocrinology 110 2 1982 506 512
47. N. Suda, M.T. Gillespie, K. Traianedes, H. Zhou, P.W. Ho, and D.K. Hards Expression of parathyroid hormone-related protein in cells of osteoblast lineage J. Cell. Physiol. 166 1 1996 94 104
48. B.O. Oyajobi, A. Lomri, M. Hott, and P.J. Marie Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using stro-1 monoclonal antibody J. Bone Miner. Res. 14 3 1999 351 361
49. L.K. McCauley, A.J. Koh, C.A. Beecher, Y. Cui, T.J. Rosol, and R.T. Franceschi PTH/PTHrP receptor is temporally regulated during osteoblast differentiation and is associated with collagen synthesis J.Cell Biochem. 61 4 1996 (6-15) 638 647
50. H. Sudo, H.A. Kodama, Y. Amagai, S. Yamamoto, and S. Kasai In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria J. Cell Biol. 96 1 1983 191 198
51. L.D. Quarles, D.A. Yohay, L.W. Lever, R. Caton, and R.J. Wenstrup Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development J. Bone Miner. Res. 7 6 1992 683 692
52. H. Ihara, D.T. Denhardt, K. Furuya, T. Yamashita, Y. Muguruma, and K. Tsuji Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin J. Biol. Chem. 276 16 2001 (4-20) 13065 13071
53. M. Noda, and G.A. Rodan Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone J. Cell Biol. 108 2 1989 713 718
54. N.C. Partridge, S.R. Bloch, and A.T. Pearman Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression J. Cell. Biochem. 55 3 1994 321 327
55. A. Wang, J.A. Martin, L.A. Lembke, and R.J. Midura Reversible suppression of in vitro biomineralization by activation of protein kinase A J. Biol. Chem. 275 15 2000 (4-14) 11082 11091
56. H.J. Leis, W. Hulla, R. Gruber, E. Huber, D. Zach, and H. Gleispach Phenotypic heterogeneity of osteoblast-like MC3T3-E1 cells: changes of bradykinin-induced prostaglandin E2 production during osteoblast maturation J. Bone Miner. Res. 12 4 1997 541 551